| 1 |
34561887 | Proteolytic activation of SARS-CoV-2 spike protein. | 2022 Jan |
1 |
| 2 |
34826419 | Hydroxychloroquine treatment on SARS-CoV-2 receptor ACE2, TMPRSS2 and NRP1 expression in human primary pterygium and conjunctival cells. | 2022 Jan |
1 |
| 3 |
35104687 | A common TMPRSS2 variant has a protective effect against severe COVID-19. | 2022 May |
1 |
| 4 |
35128036 | Discovery of novel TMPRSS2 inhibitors for COVID-19 using in silico fragment-based drug design, molecular docking, molecular dynamics, and quantum mechanics studies. | 2022 |
1 |
| 5 |
35170548 | Potential applications of prognostic and immunological marker transmembrane serine proteinase 2 in prediction, prevention and personalized treatment of lung cancer. | 2022 Mar 3 |
1 |
| 6 |
35294338 | Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry. | 2022 Mar 23 |
1 |
| 7 |
35338216 | Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19. | 2022 Mar 25 |
1 |
| 8 |
35344983 | A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic. | 2022 May |
1 |
| 9 |
35631327 | Camostat Does Not Inhibit the Proteolytic Activity of Neutrophil Serine Proteases. | 2022 Apr 20 |
1 |
| 10 |
32972339 | Targeting Host Cell Proteases to Prevent SARS-CoV-2 Invasion. | 2021 |
2 |
| 11 |
33164230 | Insights into disparities observed with COVID-19. | 2021 Apr |
1 |
| 12 |
33239231 | Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19. | 2021 Jan |
1 |
| 13 |
33268377 | Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection. | 2021 Jan-Jun |
1 |
| 14 |
33467896 | Inter-proteomic posttranslational modifications of the SARS-CoV-2 and the host proteins ‒ A new frontier. | 2021 Apr |
2 |
| 15 |
33619331 | Serine 477 plays a crucial role in the interaction of the SARS-CoV-2 spike protein with the human receptor ACE2. | 2021 Feb 22 |
1 |
| 16 |
33706067 | Why blood group A individuals are at risk whereas blood group O individuals are protected from SARS-CoV-2 (COVID-19) infection: A hypothesis regarding how the virus invades the human body via ABO(H) blood group-determining carbohydrates. | 2021 May |
1 |
| 17 |
33737214 | Structural and molecular perspectives of SARS-CoV-2. | 2021 Nov |
1 |
| 18 |
33741941 | Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection. | 2021 Mar 19 |
1 |
| 19 |
33821268 | Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry. | 2021 Jul 30 |
1 |
| 20 |
34127969 | FXa cleaves the SARS-CoV-2 spike protein and blocks cell entry to protect against infection with inferior effects in B.1.1.7 variant. | 2021 Jun 8 |
1 |
| 21 |
34336361 | A Review on Expression, Pathological Roles, and Inhibition of TMPRSS2, the Serine Protease Responsible for SARS-CoV-2 Spike Protein Activation. | 2021 |
1 |
| 22 |
34393265 | Computational studies reveal Fluorine based quinolines to be potent inhibitors for proteins involved in SARS-CoV-2 assembly. | 2021 Oct |
2 |
| 23 |
34449057 | The rapid adaptation of SARS-CoV-2-rise of the variants: transmission and resistance. | 2021 Sep |
1 |
| 24 |
34541574 | Broad antiviral and anti-inflammatory efficacy of nafamostat against SARS-CoV-2 and seasonal coronaviruses in primary human bronchiolar epithelia. | 2021 Jun 30 |
1 |
| 25 |
32404436 | TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. | 2020 May 13 |
1 |
| 26 |
32589459 | Ocular Surface Expression of SARS-CoV-2 Receptors. | 2020 Jul 3 |
1 |
| 27 |
32638018 | Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart. | 2020 Aug 1 |
1 |
| 28 |
32741259 | Identification of potential anti-TMPRSS2 natural products through homology modelling, virtual screening and molecular dynamics simulation studies. | 2020 Aug 3 |
2 |
| 29 |
33278189 | Is Spironolactone the Preferred Renin-Angiotensin-Aldosterone Inhibitor for Protection Against COVID-19? | 2020 Dec 4 |
1 |
| 30 |
33290397 | Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection. | 2020 Dec |
1 |
| 31 |
33293627 | SARS-CoV-2 receptor ACE2 is co-expressed with genes related to transmembrane serine proteases, viral entry, immunity and cellular stress. | 2020 Dec 8 |
1 |
| 32 |
33299610 | SARS-CoV-2, Early Entry Events. | 2020 |
2 |